edoc

Items where Division is "03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Myeloid Malignancies (Meyer S)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: 2022 | 2016 | 2015
Number of items at this level: 3.

2022

Soni, Kunal. Experimental study of radio-frequency plasma surface interactions on diagnostic mirrors under ITER-relevant environments. 2022, Doctoral Thesis, University of Basel, Faculty of Science.

2016

Grisouard, Jean and Li, Sai and Kubovcakova, Lucia and Rao, Tata Nageswara and Meyer, Sara C. and Lundberg, Pontus and Hao-Shen, Hui and Romanet, Vincent and Murakami, Masato and Radimerski, Thomas and Dirnhofer, Stephan and Skoda, Radek C.. (2016) JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood, 128 (6). pp. 839-851.

2015

Meyer, S. C. and Keller, M. D. and Chiu, S. and Koppikar, P. and Guryanova, O. A. and Rapaport, F. and Xu, K. and Manova, K. and Pankov, D. and O'Reilly, R. J. and Kleppe, M. and McKenney, A. S. and Shih, A. H. and Shank, K. and Ahn, J. and Papalexi, E. and Spitzer, B. and Socci, N. and Viale, A. and Mandon, E. and Ebel, N. and Andraos, R. and Rubert, J. and Dammassa, E. and Romanet, V. and Dolemeyer, A. and Zender, M. and Heinlein, M. and Rampal, R. and Weinberg, R. S. and Hoffman, R. and Sellers, W. R. and Hofmann, F. and Murakami, M. and Baffert, F. and Gaul, C. and Radimerski, T. and Levine, R. L.. (2015) CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer Cell, 28 (1). pp. 15-28.

This list was generated on Fri Mar 29 03:52:51 2024 CET.